Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative recombinant human erythropoietin in stage II/III breast cancer mastectomy patients
ACTRN12610000813088Phase 2Completed
- Sponsor
- University Hospital of Ioannina
- Start
- Feb 2000
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of erythropoietin in breast cancer (2 arms), sponsored by University Hospital of Ioannina. Primary endpoint: Assessment of cytokine cascade expression with plasma and drainage fluid cytokine assays following immunomodulation by recombinant human erythropoietin. Started Feb 2000; status: completed.
02
Drugs
erythropoietin
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12610000813088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000813088.